Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Viral Modulation of RIPK3: Innovations in Necroptosis and In
2026-05-21
Liu et al. uncovered a class of orthopoxvirus-encoded proteins that induce degradation of the necroptosis adaptor RIPK3, thereby regulating virus-induced inflammation and pathogenesis. This mechanistic insight advances understanding of viral immune evasion and supports refined experimental strategies for cell death and inflammation research.
-
Olsalazine Sodium Applied: Workflows for Cancer and Inflamma
2026-05-21
Olsalazine Sodium, a mesalamine dimer, empowers cutting-edge inflammation and colorectal cancer models through potent LTB4 chemotaxis inhibition, robust apoptosis induction, and high water solubility for streamlined experimental design. This article delivers protocol-ready guidance, assay optimization strategies, and novel cross-domain insights from recent transporter research.
-
Optimized hiPSC Differentiation for Cost-Effective Platelet
2026-05-20
This study presents a systematically refined protocol that significantly increases the efficiency and reduces the cost of generating functional platelets from human induced pluripotent stem cells (hiPSCs). The approach integrates enhanced embryoid body seeding, serum-free media with human platelet lysate, and targeted small molecule supplementation, offering a scalable solution for platelet manufacturing.
-
Microglial Activation and Neuronal Dysregulation in Alcohol-
2026-05-20
This study identifies microglial activation as a critical driver of neuronal circuit dysregulation and enhanced seizure susceptibility following acute alcohol exposure. By dissecting synaptic changes in the hippocampal CA1 region, the research clarifies the interplay between neuroinflammation, GABAergic/glutamatergic signaling, and seizure risk, informing future neuroimmune-targeted interventions.
-
Patient-Derived Gastric Cancer Assembloids Advance Tumor Mod
2026-05-19
This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations. The model demonstrates enhanced physiological relevance for drug screening and mechanistic exploration of tumor–stroma interactions, offering valuable insights into therapeutic resistance and personalized medicine strategies.
-
CTCF Maintains Centromere Integrity and Mitotic Accuracy
2026-05-19
This study elucidates the essential role of CTCF in preserving centromere function and ensuring faithful chromosome segregation during mitosis. By employing rapid CTCF depletion in human cells, the authors reveal that CTCF loss disrupts centromere architecture and metaphase plate organization, providing mechanistic insight with direct implications for cell division fidelity and cancer research.
-
Sunitinib in Precision RTK Pathway Modulation: A Deep-Dive f
2026-05-18
Discover how Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, is revolutionizing translational cancer research through precision modulation of RTK pathways. This article uniquely bridges molecular mechanism with experimental strategy, offering critical insights for assay optimization and model selection.
-
GSK343 and the Future of EZH2 Inhibition in Epigenetic Oncol
2026-05-18
This article provides strategic and mechanistic insight into the role of GSK343, a potent, selective EZH2 inhibitor, in advancing translational epigenetic cancer research. By bridging mechanistic understanding with practical guidance, it explores histone H3K27 trimethylation inhibition, cellular models, recent evidence on polycomb repression, and the translational potential of EZH2 targeting. Drawing on both foundational studies and new research on TERT regulation, it offers actionable workflow recommendations and highlights APExBIO’s leadership in providing rigorously validated epigenetic tools.
-
Optimized hiPSC-to-Platelet Differentiation: Small Molecule
2026-05-17
This study presents a systematically optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs). By leveraging small-molecule modulators and refined culture conditions, the authors achieved significant gains in yield, efficiency, and cost-effectiveness, offering new avenues for translational platelet manufacturing.
-
Reserpine (N1867): Technical Guidance for Research Workflows
2026-05-16
Reserpine is a high-purity bioactive compound used to enable controlled neurotransmitter depletion and study antihypertensive mechanisms within neuropharmacology research. It is not suitable for diagnostic, clinical, or veterinary applications, and must be handled according to its specific solubility and stability requirements to ensure experimental reproducibility.
-
Harnessing Caspase-3 Assays for Translational Apoptosis Rese
2026-05-15
This thought-leadership article explores the mechanistic and strategic frontiers of apoptosis research, highlighting the central role of caspase-3 as a biomarker and effector in cell death signaling. By scrutinizing recent advances in immunology and neurodegeneration, the article positions the Caspase-3 Colorimetric Assay Kit as an indispensable tool for translational researchers, offering detailed protocol parameters, competitive benchmarks, and actionable guidance for bridging molecular insights to clinical applications. Expanded analysis is provided on the interplay between immune signaling, ER stress, and apoptosis, drawing on landmark studies and contemporary workflow best practices.
-
CHIR-99021 (CT99021): Enhancing 3D Stem Cell Differentiation
2026-05-15
CHIR-99021 (CT99021) empowers precise, reproducible stem cell modeling by modulating Wnt/β-catenin signaling and promoting pluripotency. This guide delivers actionable protocol upgrades and troubleshooting strategies—bridging foundational research with advanced 3D co-culture models and regenerative innovation.
-
Sodium Phosphate Dibasic: Optimizing Biological Assay Buffer
2026-05-14
Sodium phosphate dibasic (Na2HPO4) delivers unmatched pH stability and reproducibility as a core component in biological assay buffers. This article translates recent aquatic toxicology findings into actionable buffer protocols and troubleshooting strategies, equipping researchers with workflow enhancements for robust protein and enzyme assays.
-
PQQ Mitigates Age-Related Osteoarthritis via Nrf2–IGF1R Axis
2026-05-14
This study demonstrates that dietary pyrroloquinoline quinone (PQQ) alleviates age-related osteoarthritis in mice through activation of Nrf2-mediated antioxidant pathways and upregulation of IGF1R, reducing oxidative damage and cellular senescence. The results suggest the PQQ–Nrf2–IGF1R axis as a promising disease-modifying target for osteoarthritis intervention.
-
Aconitase Activity Colorimetric Assay Kit: Metabolic Flux as
2026-05-13
Explore advanced quantification of iron-sulfur protein aconitase in metabolic and immunometabolic research using the Aconitase Activity Colorimetric Assay Kit. This article delivers a unique perspective on dynamic metabolic flux measurement and its implications for oxidative damage and T cell function.